APVO Shares Outstanding History
Below is a table of the APVO shares outstanding history going back to 8/1/2016:

Date APVO Shares Outstanding
8/1/20161.44M
11/1/20161.45M
3/24/20171.49M
5/10/20171.51M
8/8/20171.53M
11/6/20171.53M
3/9/20181.51M
5/8/20181.61M
8/7/20181.62M
11/9/20181.62M
3/14/20193.07M
5/7/20193.22M
8/6/20193.22M
8/13/2019138619
11/6/20193.23M
3/25/20203.23M
3/27/20203.23M
8/14/20203.23M
11/10/20204.15M
3/31/20214.45M
4/26/20214.45M
5/10/20214.45M
8/11/20214.89M

Also see: APVO Market Cap History
APVO YTD Return
APVO Historical Shares Outstanding:
+27.45% CAGR
APVO Historical Shares Outstanding: +27.45% CAGR

Mouse over chart for data details
8/1/2016 ...8/11/2021
Aptevo Therapeutics is a clinical-stage biotechnology company focused on developing immunotherapies for the treatment of cancer. Co.'s lead clinical candidate, APVO436 is an ADAPTIR bispecific immunotherapeutic protein targeting CD123, a cell surface receptor highly expressed on several hematological malignancies and CD3, a component of the T-cell receptor. ALG.APV-527 is an investigational bispecific ADAPTIR candidate, partnered with Alligator Bioscience AB, featuring a mechanism of action designed to simultaneously target 4-1BB (CD137) and 5T4, a tumor antigen overexpressed in a number of different types of cancer. APVO603 is a preclinical dual agonist bispecific ADAPTIR candidate. We show 23 historical shares outstanding datapoints in our coverage of APVO's shares outstanding history.

Understanding the changing numbers of APVO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like APVO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching APVO by allowing them to research APVO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for APVO:
APVO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aptevo Therapeutics (APVO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AQB Shares Outstanding History
AQXP Shares Outstanding History
ARA Shares Outstanding History
ARAY Shares Outstanding History
ARDM Shares Outstanding History
ARDX Shares Outstanding History
ARNA Shares Outstanding History
ARQL Shares Outstanding History
ARRY Shares Outstanding History
ARWR Shares Outstanding History
More Healthcare companies »

 

APVO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.